ELVN
Enliven Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD54.33
+2.66 (+5.15%)
Rating:C+
Company Profile
CEO
Richard A. Fair
IPO Date
2020-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$52.50
Prev. Close
$51.67
Day Low
$52.00
Day High
$54.88
52W Low
$14.79
52W High
$54.88
Market Cap
$3.88B
Volume
0.64M